Pyruvate Kinase M2: A Potential Regulator of Cardiac Injury Through Glycolytic and Non-glycolytic Pathways

Chenxin Zeng1,2, Jiangfeng Wu1,3, Junming Li1,2

  • 1The First College of Clinical Medical Sciences, China Three Gorges University, Yichang, China.

Insights

Pyruvate kinase M2 (PKM2) plays a dual role in heart repair. Its dimeric form aids regeneration by promoting glycolysis and pentose phosphate pathway activity, while its tetrameric form supports energy production and cardiac regeneration.

Area of Science:

  • Cardiovascular Biology
  • Metabolic Regulation
  • Regenerative Medicine

Background:

  • Adult heart regeneration is limited by cardiomyocyte cell cycle arrest, increasing cardiomyopathy mortality.
  • Metabolic reprogramming, particularly glycolysis, is crucial for cardiac repair, regeneration, and fibrosis.
  • Pyruvate kinase (PK) is a key glycolytic enzyme, with PKM1 and PKM2 isoforms having significant roles post-cardiac injury.

Purpose of the Study:

  • To review the multifaceted role of Pyruvate Kinase M2 (PKM2) in cardiac injury response.
  • To elucidate PKM2's function in glycolysis, cardiomyocyte proliferation, and cardiac regeneration.
  • To explore PKM2's involvement in both protective and detrimental cardiac remodeling processes, including fibrosis.

Main Methods:

  • Review of existing literature on PKM2 function in the heart.
  • Analysis of PKM2's enzymatic activity (dimer vs. tetramer) and its downstream effects.
  • Investigation of PKM2 interactions with other signaling molecules and transcription factors.

Main Results:

  • PKM2 exists as a dimer (promoting aerobic glycolysis, pentose phosphate pathway, and regeneration) and a tetramer (supporting ATP production and regeneration via KDM5).
  • PKM2 dimers facilitate cardiomyocyte proliferation and protect against ischemic damage by activating K ATP channels.
  • PKM2 tetramers promote ATP generation and cardiac regeneration, while PKM2 also interacts with various factors influencing cardiac homeostasis and neovascularization.
  • Conversely, PKM2 is implicated in cardiac fibrosis through mechanisms involving SIRT3, TG2, TGF-β1/Smad2/3, and Jak2/Stat3 signaling.

Conclusions:

  • PKM2 exhibits a complex, context-dependent role in cardiac injury, promoting regeneration and protection in one form and potentially fibrosis in another.
  • Targeting PKM2 offers therapeutic potential for enhancing cardiomyocyte proliferation and cardiac regeneration while mitigating fibrosis.
  • Understanding PKM2's dual functions is critical for developing effective strategies for heart repair.

Related Concept Videos

What is Glycolysis?00:56

What is Glycolysis?

Overview
Cells make energy by breaking down macromolecules. Cellular respiration is the biochemical process that converts "food energy" (from the chemical bonds of macromolecules) into chemical energy in the form of adenosine triphosphate (ATP). The first step of this tightly regulated and intricate process is glycolysis. The word glycolysis originates from the Latin glyco (sugar) and lysis (breakdown). Glycolysis serves two main intracellular functions: generating ATP and generating...
164.7K
Fates of Pyruvate01:20

Fates of Pyruvate

Pyruvate is the end product of glycolysis, where glucose is oxidized to pyruvate, simultaneously reducing NAD+ to NADH. Two molecules of ATP are also produced by substrate-level phosphorylation.
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
8.4K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
144
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
13.2K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.3K